Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.05 USD | -0.29% | -7.64% | +12.66% |
Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
Apr. 29 | Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28 | MT |
Financials (USD)
Sales 2024 * | 672M | Sales 2025 * | 669M | Capitalization | 2.39B |
---|---|---|---|---|---|
Net income 2024 * | -450M | Net income 2025 * | -368M | EV / Sales 2024 * | 2.87 x |
Net cash position 2024 * | 458M | Net cash position 2025 * | 261M | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
-5.39
x | P/E ratio 2025 * |
-6.87
x | Employees | 1,022 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.63% |
Latest transcript on PTC Therapeutics, Inc.
1 day | -0.29% | ||
1 week | -7.64% | ||
Current month | -3.42% | ||
1 month | +12.50% | ||
3 months | +21.72% | ||
6 months | +65.87% | ||
Current year | +12.66% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 19-09-30 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 23-07-12 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15-06-14 |
Chairman | 72 | 01-07-31 | |
David Southwell
BRD | Director/Board Member | 63 | 05-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 0 M€ | -5.02% | ||
0.36% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 31.05 | -0.29% | 822,517 |
24-05-08 | 31.14 | -2.04% | 623,773 |
24-05-07 | 31.79 | -3.55% | 512,539 |
24-05-06 | 32.96 | -0.15% | 468,720 |
24-05-03 | 33.01 | -1.81% | 992,559 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.66% | 2.39B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- PTCT Stock